Pay-it-forward gonorrhea and chlamydia testing among men who have sex with men in China:a study protocol for a three-arm cluster randomized controlled trial by Zhang, Tiange P et al.
                          Zhang, T. P., Yang, F., Tang, W., Alexander, M., Forastiere, L., Kumar, N.,
Li, K., Zou, F., Yang, L., Mi, G., Wang, Y., Huang, W., Lee, A., Zhu, W.,
Vickerman, P., Wu, D., Yang, B., Christakis, N. A., & Tucker, J. D. (2019).
Pay-it-forward gonorrhea and chlamydia testing among men who have sex
with men in China: a study protocol for a three-arm cluster randomized
controlled trial. Infectious diseases of poverty, 8(1), [76 (2020)].
https://doi.org/10.1186/s40249-019-0581-1
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1186/s40249-019-0581-1
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BMC at
https://doi.org/10.1186/s40249-019-0581-1 . Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/pure/user-
guides/explore-bristol-research/ebr-terms/
STUDY PROTOCOL Open Access
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men in China: a study protocol for a three-
arm cluster randomized controlled trial
Tiange P. Zhang1,2, Fan Yang1, Weiming Tang1,3,4, Marcus Alexander5, Laura Forastiere5, Navin Kumar5,
Katherine Li6, Fei Zou7, Ligang Yang4, Guodong Mi8, Yehua Wang1, Wenting Huang1, Amy Lee1, Weizan Zhu9,
Peter Vickerman10, Dan Wu1, Bin Yang4, Nicholas A. Christakis5 and Joseph D. Tucker1,3,11*
Abstract
Background: Gonorrhea and chlamydia testing rates are poor among Chinese men who have sex with men
(MSM). A quasi-experimental study suggested that a pay-it-forward strategy increased dual gonorrhea/chlamydia
testing among MSM. Pay-it-forward offers an individual a gift (e.g., a free test) and then asks the same person if
they would like to give a gift to another person. This article reports the protocol of a randomized controlled trial to
evaluate dual gonorrhea/chlamydia test uptake and other outcomes among MSM in three arms – a pay-it-forward
arm, a pay-what-you-want arm, and a standard of care arm.
Methods: Three hundred MSM will be recruited at three HIV testing sites in Guangzhou and Beijing. Testing sites
include two hospital-based MSM sexually transmitted diseases clinics and one MSM community-based organization.
Eligible participants will be born biologically male, aged 16 years or older, reporting previous anal sex with another
man, having never participated in the pay-it-forward program, without previous gonorrhea and chlamydia testing
in the past 12 months, and residing in China. Following a cluster randomized design, every cluster of ten
participants will be randomly allocated into one of three arms: (1) a pay-it-forward arm in which men are offered
free gonorrhea and chlamydia testing and then asked whether they would like to donate (“pay it forward”) toward
testing for future testers; (2) a pay-what-you-want arm in which men are offered free testing and told to decide
how much to pay after receiving the test; (3) a standard of care arm in which men can pay the full price for dual
gonorrhoea and chlamydia testing. The primary outcome is dual gonorrhoea/chlamydia testing as verified by
administrative records. Secondary outcomes include incremental cost per test, incremental cost per diagnosis,
community connectedness, and social cohesion. Primary outcome will be calculated for each arm using intention-
to-treat and compared using one-sided 95% confidence intervals with a margin of 20% increase defined as
superiority.
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Discussion: This study will examine the pay-it-forward strategy in comparison to the standard of care in
improving test uptake for gonorrhea and chlamydia. We will leverage the cluster randomized controlled
trial to provide scientific evidence on the potential effect of pay-it-forward. Findings from this study will
shed light on novel intervention methods for increasing preventive health service utilization and innovate
ways to finance it among communities.
Trial registration: ClinicalTrials.gov, NCT03741725. Registered on 12 November 2018.
Keywords: Men who have sex with men, Gonorrhoea and chlamydia testing, Pay-it-forward, Integrated HIV
testing, China, Randomized controlled trial
Multilingual abstracts
Please see Additional file 1 for translations of the abstract
into the five official working languages of the United
Nations.
Background
Gonorrhea and chlamydia are among the most prevalent
sexually transmitted infections (STIs) in China [1, 2]. Men
who have sex with men (MSM) is a recognized high risk
group for STIs and is estimated to have a population of
2–10 million in China [1, 3]. One study conducted from
2015 to 2017 among MSM in Guangzhou reported an
overall gonorrhea prevalence of 12.5% and a chlamydia
prevalence of 18.1% [2]. Gonorrhea and chlamydia infec-
tions are also associated with increased risk for HIV
transmission and acquisition [4, 5]. Yet, infections are
commonly asymptomatic and easily missed without
screening, especially those at extragenital sites [6–8]. For
MSM, the World Health Organization recommends
periodic testing for asymptomatic urethral and rectal gon-
orrhea and chlamydia using nucleic acid amplification
tests (NAAT) [9]. US Centers for Disease Control and
Prevention (CDC) also suggests annual NAAT testing for
gonorrhea and chlamydia in asymptomatic MSM who are
at high risk [10].
Yet, gonorrhea and chlamydia testing rate remains low
among MSM in China [11], where studies show that less
than 50% of MSM have ever been tested [12, 13]. Factors
that contribute to poor gonorrhea and chlamydia testing
among Chinese MSM include poor government funding
for testing programs [14], inadequate linking of STI
testing to existing HIV testing systems [15, 16], and in-
sufficient MSM community involvement in STI efforts
other than HIV. First, few government incentives exist
to support the additional training and laboratory tech-
nology associated with regular gonorrhea and chlamydia
testing [14]. Second, while many HIV testing programs
for key populations have began to offer syphilis testing,
most are still not set up to facilitate comprehensive STI
testing [15, 16]. Third, MSM community organizations
have had an increasing yet still limited role in China’s
HIV/STI response [17–19]. Most community-based
outreach programs prioritize HIV, with few focused on
gonorrhea or chlamydia [20].
In light of this need, several community organizations
collaborated with public health staff to organize a gonor-
rhea and chlamydia testing pilot program using a pay-it-
forward strategy [21]. In pay-it-forward, one person is
offered a gift (e.g., a free test), then they are asked
whether they would like to give a gift to another person
[22, 23]. Pay-it-forward has been studied in behavioral
economics as a form of consumer elective pricing,
defined as an economic transaction that allows individ-
uals to purchase goods or services for any price (includ-
ing zero) [24]. Pay-it-forward chains of giving is a type
of cooperative behavior that can take place between
known or anonymous individuals [25]. In social science
experiments, pay-it-forward has been shown to promote
generosity and engage group cohesiveness [22, 24].
One pilot study found that pay-it-forward increased
gonorrhea/chlamydia testing 19-fold, with gonorrhea/
chlamydia testing received by 53.7% (109/203) in the
pay-it-forward group and 5.9% (12/205) in the standard
of care group [21]. However, this was not a randomized
controlled trial (RCT) and the study only compared two
groups of individuals. We will evaluate the pay-it-for-
ward model using a three-arm cluster randomized con-
trolled trial. The purpose of this trial is to evaluate a
pay-it-forward intervention for increasing gonorrhea and
chlamydia testing among Chinese MSM.
Methods/design
Specific aims
1) Aim 1: To compare the effectiveness of a pay-it-
forward program to standard of care in promoting
gonorrhea/chlamydia testing among Chinese MSM.
Hypothesis: Pay-it-forward is superior to the
standard of care in promoting gonorrhea/chlamydia
testing.
2) Aim 2: To compare the effectiveness of a pay-what-
you-want program to standard of care in promoting
gonorrhea/chlamydia testing among Chinese MSM.
Hypothesis: Pay-what-you-want is superior to the
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standard of care in promoting gonorrhea/chlamydia
testing.
3) Aim 3: To determine the gonorrhea/chlamydia cost
per test and the cost per case diagnosed within the
three trial arms. Hypothesis: Pay-it-forward is
associated with lower cost per test and lower cost
per case diagnosed.
Methods
Trial design and timeline
This study will be a three-arm cluster randomized con-
trolled superiority trial, with the main comparisons
being pay-it-forward vs standard of care and pay-what-
you-want vs standard of care. Men will be randomly
assigned in a 1:1:1 ratio into three arms. The three arms
of the study will include: (1) a pay-it-forward arm in
which men are offered free gonorrhea and chlamydia
testing and then given the option to donate (“pay it for-
ward”) toward testing for future testers; (2) a pay-what-
you-want arm in which men are offered free testing and
told to decide how much to pay after receiving the test;
and (3) a standard of care arm in which men can pay
the full price for dual gonorrhoea and chlamydia testing
(RMB 150, or USD 22). Men will be recruited at three
sites: two hospital-based MSM sexually transmitted
disease (STD) clinics in Guangzhou and one MSM com-
munity-based organization in Beijing.
Following a cluster randomized design, every cluster of
ten participants in each of the three study sites will be
randomly allocated into one of the three arms independ-
ently: pay-it-forward arm, pay-what-you-want arm, or
the standard of care arm. The rationale for choosing ten
participants per cluster as the unit of randomization
rather than individual participants is to minimize
contamination of intervention across individuals and to
facilitate cooperation with clinic staff. Gonorrhoea/chla-
mydia testing is performed immediately following each
trial arm. Gonorrhoea/chlamydia test uptake will be
ascertained by assessing administrative records.
Eligible men will also complete a single survey (see
Additional file 2). No follow-up surveys will be
conducted in this study.
This study will span approximately 3 months. The first
month will consist of RCT preparations and a pilot for
the RCT. The following period will consist of RCT re-
cruitment and implementation. Recruitment will con-
tinue at all sites following a cluster randomization
process until the pre-determined sample size is reached
- a process that is expected to take approximately 1.5
months. The study will be managed by the Social Entre-
preneurship to Spur Health (SESH) group, a multi-sec-
toral implementation research collaboration led by the
Southern Medical University Dermatology Hospital and
the University of North Carolina Project-China.
Study setting and recruitment
Guangzhou and Beijing are large metropolitan areas with
high burdens of STDs and HIV among MSM. The RCT
will enroll from an STD clinic and a local MSM commu-
nity-based organization (CBO) sites that provide free
HIV testing for MSM. The STD clinic site operates
within an ongoing hospital-based program; the CBO
testing site operates within an ongoing community-
based program. All sites already provide free HIV testing
to MSM, and are staffed by MSM volunteers, nurses,
and public health staff. There are no clinical doctors at
either site. The staff at each site is responsible for hand-
ling blood draws, testing, results reporting, and follow-
up of HIV tests. All sites will follow the same study
procedures.
Eligibility criteria
Potential participants must first agree to a print in-
formed consent in order to participate. Inclusion criteria
are: born biologically male, age 16 years or older, report
previous anal sex with another man, never participated
in the pay-it-forward program, and report one of the
following with regards to gonorrhoea/chlamydia testing
history: not tested for both gonorrhoea and chlamydia in
the past 12 months, report testing for both gonorrhoea
and chlamydia in the past 12 months with high-risk
sexual behaviour following testing, report previous test-
ing for either or both gonorrhoea and chlamydia but
does not recall whether tested within the past 12
months. All eligible participants must provide a working
unique mobile phone number or WeChat account iden-
tification to be enrolled. These will be used only for
results notification.
Interventions
Pay-it-forward arm The pay-it-forward (PIF) program
is developed using crowdsourcing. An open challenge
contest [26] developed the name and format of the pro-
gram materials. Hand-written postcards from previous
participants in the program will encourage testing
among future participants. Community volunteers will
provide inputs to the program. At all program sites,
MSM will be offered dual gonorrhea/chlamydia testing
during their appointments for HIV testing (Fig. 1). First,
all men will be provided a brief (5 min) introduction to
gonorrhea and chlamydia testing using a pamphlet (see
Additional file 3). Program organizers will then explain
the pay-it-forward program to each man using a pamph-
let (see Additional file 4). Briefly, men will be told that
the hospital list price of gonorrhea and chlamydia testing
is RMB 150 (USD 22), and that previous men attending
the clinic had donated money to cover the cost of this
test. Thus, each man could receive gonorrhea and
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chlamydia testing for free, then decide whether to
donate money (pay-it-forward) for future men to have
the same option. Men will be assured that donating is
voluntary and told to pay any amount as they desire. A
combination of initial research funding and donations
from previous participants will be used to cover each
man’s gonorrhea and chlamydia testing fees. Men will
also be shown a postcard with a message written in sim-
plified Chinese characters by a previous pay-it-forward
contributor and told that they could also write a post-
card message for a future participant. Men will then
decide whether or not to receive combined gonorrhea
and chlamydia testing. Regardless of their decision to
test, men will be asked to fill out a brief survey about
their sexual history, testing history, attitudes toward the
testing program, and psychosocial conditions.
MSM who decide to test will be asked about their
sexual practices and will be advised to consider receiving
urine, anal, or both urine and anal dual gonorrhea/chla-
mydia testing. All participants will be advised that their
information will be kept confidential, and that the
results will be sent to them after approximately 1 week
via WeChat, a phone- and computer-based instant mes-
saging application. Men who agree to participate will
choose to collect the sample on their own or have a staff
member assist with sample collection [27]. After sample
collection, men will decide whether or not to donate
money to the next group of participants. Men can
choose to leave donations for future participants with
the program organizers via either cash or WeChat’s
monetary transfer functionality. Each man will then be
invited to write a message on a postcard for future pay-
it-forward participants.
Program organizers will inform participants of their
test results via WeChat. Samples collected in Guangzhou
will be stored at room temperature overnight and then
transported to Southern Medical University Dermatol-
ogy Hospital in Guangzhou for laboratory testing within
1 week. Samples collected in Beijing will be shipped
in insulated shipping container to Southern Medical
University Dermatology Hospital for laboratory test-
ing within 1 week. Patients who test positive will be
counseled and directed to the WeChat page of the
designated partnering hospital in each city, where
they are able to make an appointment to receive
treatment and follow-up.
Pay-what-you-want arm Pay-what-you-want (PWYW)
is a well-documented pricing strategy where the buyers
decide and pay their desired amount for a given product
or service, which is usually consumed by themselves
[24]. Financially, pay-what-you-want is identical to pay-
it-forward pricing: the customers choose the price they
want to pay for a certain good or service, and the seller
receives the payments. Socially, pay-what-you-want is
different in that the customer is paying for him- or
Fig. 1 Schematic of three trial arms. The block diagrams describe the implementation steps for each arm
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herself, while in pay-it-forward the customer is paying
on behalf of someone else. Just as the pay-it-forward
arm, MSM will be offered dual gonorrhea/chlamydia
testing during their appointments for HIV testing. First,
all men will be provided a brief (5 min) introduction to
gonorrhea and chlamydia testing using a pamphlet. Pro-
gram organizer will then explain the pay-what-you-want
program to each man separately using verbal descrip-
tions. Briefly, men will be told that the hospital list price
of gonorrhea and chlamydia testing was RMB 150 (USD
22). Then they will be told that if they were to test today,
they can participate in the pay-what-you-want program,
in which they receive the test first and then decide how
much they would like to pay. Men will be assured that
payment is completely optional and advised to pay any
amount that is desired by them. Men will then decide
whether or not to receive urine, anal, or both urine and
anal dual gonorrhea/chlamydia testing. Each man’s
gonorrhea and chlamydia test fees will be covered by a
combination of the initial research funding from the
program organizers and payments from participants.
All participants will be ensured that their information
will be kept confidential. Procedures for sample collec-
tion, sample processing, payment method, results report-
ing, and treatment linkage will be identical to those of
the pay-it-forward arm.
Standard of care arm Among men assigned to the
standard of care arm, gonorrhea and chlamydia testing
will be offered at the usual hospital list price (RMB 150,
USD 22). All men will be provided a brief introduction
about gonorrhea and chlamydia testing using the same
pamphlet, but will not be introduced to other content of
the above arms. Procedures for sample collection, sam-
ple processing, payment method, results reporting, and
treatment linkage will be identical to those of the pay-it-
forward arm.
Randomization and allocation
At each site, men will be assigned to one of the three
arms through a cluster randomization procedure with
ten participants per cluster (Fig. 2). To ensure equal
Fig. 2 Schematic of cluster randomization procedure and sample allocation. This schematic diagram illustrates the cluster randomization
procedure, average volume of testers who visit the study site for HIV tests during a typical week, and allocation. There are 30 clusters
and 300 total participants, which satisfy the sample size. The sequence shown is for illustration and is not the actual allocation sequence
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number of clusters in each of the three arms, the clus-
ters will be randomized in a block of three at each study
site. The schedule will be determined prior to start of
the study and then provided to each of the sites. STATA
15.1 software (StataCorp, StataCorp LLC, College
Station, Texas) will be used to create the allocation se-
quence [28]. Ten blocks will be generated in total. Each
block has three clusters consisting of pay-it-forward,
pay-what-you-want, and standard of care, randomly cre-
ated from all possible permutations.
Each eligible individual who presents to the site during
a given 10-person cluster will be provided the allocated
program. This RCT is not blinded. Participants will be
able to determine their assignment based on whether
they received intervention materials during the study
period. Study organizers will be aware of randomization
assignment because intervention materials provided to
participants.
Laboratory testing
All urine and anal samples will be analyzed using Cobas
4800 CT/NG DNA detection kits (Roche Diagnostics,
Basel, Switzerland) at Southern Medical University
Dermatology Hospital. At the two MSM STD clinic
sites, HIV testing will be performed using the Diagnostic
Kit for Antibody to HIV ½ (Abon Pharmaceuticals,
Northvale, New Jersey, USA) and syphilis testing, for
those that choose to test, will be performed using the
Treponema Pallidum Antibodies Rapid Test (Abon
Pharmaceuticals, Northvale, New Jersey, USA). At the
CBO site, HIV testing will be performed using the Third
Generation Diagnostic Kit for Antibody to HIV rapid
test (InTec, Xiamen, China) and syphilis testing, for
those choosing to test, will be performed using the Syph-
ilis Antibody (anti-Treponema Pallidum) rapid test
(InTec, Xiamen, China).
Sample size
Sample size calculation (Table 1) is informed by a quasi-
experimental study conducted in 2017–2018 at two
similar study sites [21] and by a pilot study for the RCT
conducted from October to November 2018. In the
quasi-experimental study, gonorrhea/chlamydia testing
was 53.7% in the pay-it-forward group and 5.9% in the
standard of care group. In the pilot study for the RCT
(Table 2), gonorrhea/chlamydia testing was 88% in the
pay-it-forward group and 42% in the pay-what-you-want
group. Based on these results and pilot data for the
RCT, we assume that in the RCT we will have 54% test
uptake in the pay-it-forward group, 42% test uptake in
Table 1 Sample size calculations
Pay-it-forward and standard of care ICC 0.01 0.05
Proportion in control group 0.06 0.06
Superiority margin 0.2 0.2
Proportion in intervention group assuming H0 0.26 0.26
Proportion in intervention group assuming H1 0.54 0.54
Difference at which power is calculated 0.48 0.48
Number of people per cluster 10 10
Alpha 0.05 0.05
Power 0.8 0.8
Total sample size per arm 30 40
Number of clusters per arm 3 4
Pay-what-you-want and standard of care ICC 0.01 0.05
Proportion in control group 0.06 0.06
Superiority margin 0.2 0.2
Proportion in intervention group assuming H0 0.26 0.26
Proportion in intervention group assuming H1 0.42 0.42
Difference at which power is calculated 0.36 0.36
Number of people per cluster 10 10
Alpha 0.05 0.05
Power 0.8 0.8
Total sample size per arm 80 110
Number of clusters per arm 8 11
ICC Intra-class correlation
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the pay-what-you-want group, and 6% in the standard of
care. For the pay-it-forward uptake estimate, we chose
to use the quasi-experimental study results (54%) instead
of the pilot results (88%) because the quasi-experimental
study was considered more similar in nature to our
RCT, given that the pilot focused primarily on imple-
mentation optimization.
We will have three arms -- pay-it-forward, pay-what-
you-want, standard of care, with numbers of clusters at
a ratio of 1:1:1. The trial between pay-it-forward and
standard of care will be testing superiority in promoting
gonorrhea/chlamydia test uptake at a superiority margin
of 0.2 (20% difference in percentage agreeing to test in
those two arms). This margin was chosen as a clinically
significant difference in test uptake based on results
from a modeling study [29]. Similarly, the trial between
pay-what-you-want and standard of care will be also
testing superiority with the same margin of 0.2. Assum-
ing we will have three equal sized arms, with cluster size
of 10 per cluster, alpha of 0.05, power of 0.8, inter class
correlation of 0.01 or 005, we will at most need eight or
11 clusters per arm, respectively (Table 1). To integrate
the sample size calculations and to consider practicality,
the final sample size would be ten clusters in pay-it-for-
ward, ten clusters in pay-what-you-want, and ten clus-
ters in standard of care, with a total cluster size of 30
(300 participants).
Quality control
We will examine data collected from all participants. We
will deduplicate participants by examining cell phone
number and WeChat handle. The primary outcome for
this study is uptake of dual gonorrhea/chlamydia testing
by administrative record as a single outcome. For the pay-
it-forward arm, we will record the amount that each
participant donates to future participants. For the pay-
what-you-want arm, we will record the amount that
participants pay for their own test.
Information on socio-demographics, sexual behaviors,
HIV/STI testing history, and psychosocial conditions will
be collected using a standardized survey instrument.
Socio-demographic characteristics include participants’
age, ethnicity, marital status, highest level of education
completed, place of residency (urban or rural), and
annual income level. Sexual behaviors and HIV/STI test-
ing history include previous anal sex with men, role
during anal sex, number of sex partners, condom use,
sexual orientation disclosure, endorsement of STI symp-
toms, and testing history for HIV, gonorrhea, and chla-
mydia. Psychosocial variables include adapted measures for
community engagement [30], community connectedness
[31], identify fusion [32], and social cohesion [33, 34]. For
all participants, we will collect HIV test results, as well as
gonorrhea and chlamydia results for those who tested. We
will also collect information on reasons for accepting or
declining gonorrhea and chlamydia tests. For men assigned
to the pay-it-forward group, we will also ask about
perceived benefits and barriers of the pay-it-forward
program. Upon completion of the study survey, participants
will receive a pen valued approximately one USD.
Outcomes
The main outcome of this study will be gonorrhea and
chlamydia testing by PCR as assessed by administrative
records. The choice of diagnostics is based on World
Health Organization and US CDC guidelines recom-
mending regular gonorrhea/chlamydia testing among
MSM with risks [9, 10]. Secondary outcomes will
include incremental cost per test, incremental cost per
diagnosis, community connectedness, and social cohe-
sion. Effect modification analysis will include community
engagement. Existing literature on community engage-
ment [30], community connectedness [31, 32], and social
cohesion [33, 34], informed the development of adapted
scales in this study. Community engagement is mea-
sured using an adapted six-item yes/no scale used in a
Table 2 Two piloted arms and the historical standard of care
Arms Standard of carea Pay-it-forward Pay-what-you-want
Days piloted 52 4 5
Number of MSM offered intervention 205 17 26
GC/CT test uptake 12 (6%) 15 (88%) 11 (42%)
Number of MSM who contributed any amount NA 15 (100%) 10 (91%)
Total contribution amount NA RMB 833.88 (USD 125.08) RMB 465.99 (USD 69.90)
Average contribution Amount per tester NA RMB 55.59 (USD 8.34) RMB 42.36 (USD 6.35)
Gonorrhea positive NA 0 0
Chlamydia positive NA 2 1
MSM Men who have sex with men
GC/CT Gonorrhea and chlamydia
NA Not applicable
aHistorical standard of care data from a quasi-experimental study between March 11th and May 1st, 2018
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previous study on Chinese MSM [30]. A six-item com-
munity connectedness scale [31] and a seven-item social
cohesion scale [33, 34] ask participants to rank their
level of disagreement and agreement with each item
using answer choices “Strongly Agree,” “Agree,” “Dis-
agree” and “Strongly Disagree”. All three community
scales were adapted to the local context and piloted
among 43 Chinese MSM before RCT recruitment.
Survey items are detailed in Additional file 2.
Confidentiality
Survey data will be collected partially from online-based
questionnaire and then stored on a secure online survey
platform (Wenjuanxing), and partially from paper-based
questionnaire. Electronic data will be transmitted using
128-bit encryption across the Internet and mobile data
networks. Paper-based data will be entered by research
staff members on the same day as data collection. Re-
sponses to surveys, including participant mobile phone
numbers and WeChat account numbers, will be stored
on a secure server (electronic) and in a locked cabinet
(offline), which can be accessed with login information
known only to the research team.
Monitoring
A data monitoring committee will not be formed for this
RCT because potential for harm to participants is min-
imal. If any person feels they have experienced an
adverse event or unwanted effect from participating in
this RCT, they can withdraw at any time. A telephone
number and WeChat account will be provided to partici-
pants to contact the primary investigator with questions
or concerns.
Data analysis
Primary analysis
Socio-demographic characteristics will be summarized
using descriptive statistics. The gonorrhoea/chlamydia
test uptake rate will be calculated for each of the three
arms. Generalized estimating equations will be used to
account for potential correlation in outcomes due to
clustering. The primary analysis will evaluate the
hypotheses that the pay-it-forward intervention is super-
ior to standard of care and that the pay-what-you-want
intervention is superior to standard of care. The trial
between pay-it-forward and standard of care will be test-
ing superiority in promoting test uptake at a superiority
margin of 20% in percentage agreeing to test in those
two arms [29]. The trial between pay-what-you-want
and standard of care will be testing with the same 20%
margin. One-sided 95% confidence interval will be com-
puted for pay-it-forward vs standard of care and for pay-
what-you-want vs standard of care, and then compared
to the superiority margin.
Subgroup analysis
Effect modification analyses will evaluate whether the ef-
fect of the pay-it-forward intervention on gonorrhoea/
chlamydia test uptake varied in relation to the following
factors: (1) younger age (less than 28 years old, 28 or
older); (2) community-level constructs: community en-
gagement (high or low level), community connectedness
(high or low level), social cohesion (high or low level).
For each factor of interest, three measures of association
will be calculated: A) a crude measure of association be-
tween treatment group and test uptake, B1) a measure
of association between treatment group and test uptake
among all participants who report the factor of interest
(younger age, or high level of a community-level con-
struct), B2) a measure of association between treatment
group and test uptake among all participants who deny a
history of having the factor of interest (younger age, or
high level of a community-level construct). Effect modi-
fication will be deemed present when B1 and B2 are
different from one another, and at least one (B1 or B2)
is different from A.
Missing data plan
Men will only be involved at a single time point and so
there is no loss to follow up. However, there may be
missing data in the primary and secondary outcomes. If
the primary outcome is missing for < 15% of partici-
pants, analyses will use a complete-case approach. If an
outcome is missing for ≥15% of participants, missingness
mechanism will be investigated and multiple imputation
will be used if suitable.
Secondary analyses
Within each arm of the study, we will calculate the in-
cremental cost per test and the incremental cost per
diagnosis. Cost will be collected from the perspective of
the program provider. To estimate the program cost, we
will identify the cost of each program element, such as
personnel, facilities, equipment, and materials, and
categorize costs into start-up costs, fixed costs, and vari-
able costs. Start-up costs are incurred in the period
between the decision to implement this trial and the
start of trial recruitment (e.g. personnel training, testing
sites coordination, pilot study). Fixed costs remain
constant during the trial period regardless of the number
of people served (e.g. administration, durable goods, and
equipment). Variable costs are those that vary with the
number of participants served (e.g. recruitment, counsel-
ling and testing, and nondurable goods and supplies).
Personnel costs will be calculated by multiplying the
staff time associated with each program activity by the
compensation received by the staff who perform these
activities. We will first calculate the total cost for each
group, then divide these costs by the number of men
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tested and by the number of cases diagnosed with
gonorrhea or chlamydia.
Pilot study results summary
To inform the development of this randomized con-
trolled trial, the pay-it-forward and pay-what-you-want
arms were evaluated through a pilot study conducted
from October 2018 to November 2018 (Table 2).
A total of 43 eligible MSM were recruited at the
selected study sites for the RCT. Recruitment took place
on 9 days interspersed between 13 October and 15
November All men on a given day were assigned to
either pay-it-forward or pay-what-you-want arm. In
total, 17 men were recruited for the pay-it-forward arm
over 4 days; 26 men were recruited for the pay-what-
you-want arm over 5 days. Of these, 88% (15/17) of men
received gonorrhea/chlamydia testing in the pay-it-for-
ward arm and 42% (11/26) of men received gonorrhea/
chlamydia testing in the pay-what-you-want arm. All
men (100%, 15/15) in the pay-it-forward arm donated
some amount, with average donation per participant of
RMB 56. 91% (10/11) of men in the pay-what-you-want
paid some amount, with average payment per participant
of RMB 42. None were diagnosed with gonorrhea and
three men were diagnosed with chlamydia.
These pilot results, along with results of a quasi-ex-
perimental study among 408 men [21], were used as the
basis to inform sample size calculation. Through this
pilot period, implementation steps and survey instru-
ment were also optimized through an iterative process
consisting of feedback from MSM participants, orga-
nizers, and community partners.
Discussion
This trial will assess the effectiveness of pay-it-forward
intervention in promoting gonorrhoea and chlamydia
testing among Chinese MSM, a marginalized population
where sustainable strategies for integrated HIV/STD
testing programs are urgently needed. Few studies have
evaluated the use of pay-it-forward interventions focused
on improving health, and none to our knowledge have
used a RCT design. This three-arm cluster RCT will
demonstrate pay-it-forward’s ability to be effective in the
complex context of local settings. The pay-it-forward
model includes both free or subsidized testing and a
sense of social obligation to contribute to the health of
other gay men. With comparison to the pay-what-you-
want arm, a model that is financially similar to pay-it-
forward but socially contrasting, there is an opportunity
to explore the extent to which social and financial
factors contribute to pay-it-forward health programs.
Although this trial will yield important insights for
STD testing programming in China, some limitations
exist. The RCT will be conducted at sites of HIV/syphilis
testing for MSM. This limits our sample to MSM who
are undergoing HIV/syphilis testing and are connected
with community-based organizations. The level of trust
that MSM hold toward sites in which pay-it-forward
programs are embedded may influence program effect-
iveness. The testing sites in this study are long-standing
programs and trusted by the MSM community. Findings
may be limited in generalizability to settings that lack
existing HIV testing services or trusted sites for MSM.
Our study will generate important research and policy
implications regarding the use of pay-it-forward to pre-
ventative health services. The study outcomes will help
guide policy and intervention practice of governmental
departments and community-based organizations re-
garding the expansion of key population STD testing
strategies. Moreover, practical knowledge gained from
developing and implementing an innovative, pay-it-for-
ward intervention may be applicable for future efforts to
build self-sustaining STD testing programs.
Trial status
At the time of writing this article, RCT recruitment is
ongoing. Data analysis for the RCT has not begun. The
study is registered in the ClinicalTrials.gov database
(NCT03741725). The database will also be used for
documenting protocol modifications. The trial protocol
conforms to the Standard Protocol Items: Recommenda-
tion for Interventional Trials (SPIRIT) 2013 statement.
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